Caidya
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 2000 employees in more than 30 countries throughout the world.
Locations
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Cardiovascular
- Central Nervous System (CNS)
- Endocrinology
- Immunology
- Infectious Diseases
- Nephrology
- Oncology
- Ophthalmology
- Rare Disease
- Respiratory
- Urology
- Vaccines